Campus Hospital Universitario Virgen del Rocío - Instituto de Biomedicina de Sevilla (IBIS)

Seville 41014

0 studies enrolling now · 2 studies all time

What they study most

Gastric Cancer, HR+/HER2- Breast Cancer, Melanoma, Non Small Cell Lung Cancer, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Renal Cell Carcinoma, Triple Negative Breast Cancer, Urothelial Carcinoma

Studies at this site

• A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early